Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Hope may be on the horizon, however, according to a new pilot study published on June 17 in Headache: The Journal of Head and Face Pain. This discovery may lead to a novel treatment approach that ...

Called liraglutide, the drug is in the same family as the blockbuster weight-loss drugs Ozempic and Wegovy, which have taken the world by storm. In a small trial of 31 people with chronic migraines ...

Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.

Despite a multitude of treatment options, some migraine sufferers cannot find relief in available drugs. Others experience side effects that prevent the use of certain available migraine medications.

Ozempic-like drugs used to treat type 2 diabetes and obesity may also treat migraine, even when the medications don't trigger weight loss, early research suggests. A preliminary report, published ...

Researchers say GLP-1 medicines might be able to help with migraines.

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Medications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in ...

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers ...